Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Antibiotics to Prevent Infection and Wound Dehiscence After Obstetric Perineal Tear
NCT05830162Phase 4Completed
- Start
- Mar 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amoxicillin + clavulanate in Infection and wound dehiscence (2 arms). Primary endpoints: Infection in the obstetric tear and Wound dehiscence. Started Mar 2023; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Infectionwound dehiscence
Beyond the preview
Go deeper on NCT05830162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05830162.